首页> 外文期刊>Gene therapy >Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
【24h】

Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.

机译:使用逆转录病毒转导的髓系树突状细胞在体外诱导同种抗原特异性T细胞无反应,体内CTLA4Ig基因递送和表达的可行性。

获取原文
获取原文并翻译 | 示例
           

摘要

Dendritic cells (DC) are highly specialised, bone marrow (BM)-derived antigen-presenting cells (APC) that initiate and regulate immune responses. They provide costimulatory signals (in particular, CD40 and the CD28 ligands CD80 and CD86) necessary for naive T cell activation. Functional expression of CD80 and CD86 is blocked by the fusion protein cytotoxic T lymphocyte antigen 4-immunoglobulin (CTLA4Ig), that promotes tolerance induction in animals. Here, replicating mouse (B10; H2b) myeloid DC progenitors, were retrovirally transduced to express CTLA4Ig using the centrifugal enhancement method. Gene product was detected by immunocyto- or histochemistry. Maximal DC transduction efficiency was 62%. Compared with control, zeomycin-resistance gene (Zeo)-transduced DC, CTLA4Ig-expressing cells showed markedly impaired capacity to stimulate naive allogeneic (C3H; H2k) T cell proliferation and cytotoxic T lymphocyte (CTL) generation. Their ability to induce alloantigen-specific T cell hyporesponsiveness was reversed by exogenous IL-2 in secondary mixed leukocyte reactions (MLR). Following local (s.c.) transfer to allogeneic recipients, the genetically modified DC trafficked to T cell areas of draining lymphoid tissue, where transgene expression was detected. Ex vivo analysis of proliferative and CTL responses revealed donor-specific inhibition of alloimmune reactivity by the CTLA4Ig-transduced DC. This effect was associated with marked inhibition of interferon (IFN)-gamma production, but significant augmentation of IL-4 and IL-10 secretion. Thus, retroviral transduction of DC permits in vivo delivery of CTLA4Ig to the precise microenvironment where antigen (Ag) presentation occurs. Comparatively nonimmunogenic retroviral vectors, that allow permanent transgene expression in DC, and promote localized delivery of the immunosuppressive transgene product, promote immune deviation and Ag-specific T cell hyporesponsiveness.
机译:树突状细胞(DC)是高度专业化的骨髓(BM)衍生的抗原呈递细胞(APC),可启动和调节免疫反应。它们提供了天然T细胞活化所必需的共刺激信号(特别是CD40和CD28配体CD80和CD86)。 CD80和CD86的功能性表达被融合蛋白细胞毒性T淋巴细胞抗原4-免疫球蛋白(CTLA4Ig)阻断,从而促进动物的耐受性诱导。在这里,使用离心增强方法逆转录病毒转导复制型小鼠(B10; H2b)髓样DC祖细胞以表达CTLA4Ig。通过免疫细胞化学或组织化学检测基因产物。最大直流换能效率为62%。与对照组相比,表达霉素的抗性基因(Zeo)转导的DC,表达CTLA4Ig的细胞刺激幼稚异体(C3H; H2k)T细胞增殖和细胞毒性T淋巴细胞(CTL)生成的能力明显受损。它们在第二混合白细胞反应(MLR)中被外源IL-2逆转了它们诱导同种抗原特异性T细胞低反应性的能力。在向异基因受体局部转移后,经基因改造的DC运至淋巴组织的T细胞区域,在那里检测到转基因表达。增殖和CTL反应的离体分析显示,CTLA4Ig转导的DC对供体特异性抑制同种免疫反应性。该作用与干扰素(IFN)-γ产生的明显抑制有关,但IL-4和IL-10分泌显着增加。因此,DC的逆转录病毒转导允许将CTLA4Ig体内递送至发生抗原(Ag)呈递的精确微环境。相对非免疫原性逆转录病毒载体,可在DC中永久表达基因,并促进免疫抑制性转基因产物的局部递送,促进免疫偏差和Ag特异性T细胞反应低下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号